Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder

NCT ID: NCT00914836

Last Updated: 2015-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of corticosteroid subacromial injections have been found to be effective for the treatment of shoulder pain. Higher doses may be better than lower doses for subacromial corticosteroid injection for rotator cuff tendonitis. The investigators aim this study to compare 2 doses of corticosteroids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tendonitis Bursitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 cc - Betamethasone Sodium Phosphate

1 cc - Betamethasone Sodium Phosphate

Group Type ACTIVE_COMPARATOR

Betamethasone Sodium Phosphate

Intervention Type DRUG

1cc:2cc

1 cc - Betamethasone Sodium Phosphate

Intervention Type DRUG

Betamethasone Sodium Phosphate

2 cc - Betamethasone Sodium Phosphate

2 cc - Betamethasone Sodium Phosphate

Group Type ACTIVE_COMPARATOR

Betamethasone Sodium Phosphate

Intervention Type DRUG

1cc:2cc

2 cc - Betamethasone Sodium Phosphate

Intervention Type DRUG

Betamethasone Sodium Phosphate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Betamethasone Sodium Phosphate

1cc:2cc

Intervention Type DRUG

1 cc - Betamethasone Sodium Phosphate

Betamethasone Sodium Phosphate

Intervention Type DRUG

2 cc - Betamethasone Sodium Phosphate

Betamethasone Sodium Phosphate

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

diprospan diprospan diprospan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* subacromial bursitis
* tendinitis
* Calcific Tendonitis

Exclusion Criteria

* rotator cuff tear
* osteoarthritis
* pregnancy
* local or systemic infection
* steroid or lidocaine sensitivity
Minimum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HaEmek Medical Center, Israel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

haemek medical center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haemek Medical Center

Afula, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

References

Explore related publications, articles, or registry entries linked to this study.

van der Heijden GJ, van der Windt DA, Kleijnen J, Koes BW, Bouter LM. Steroid injections for shoulder disorders: a systematic review of randomized clinical trials. Br J Gen Pract. 1996 May;46(406):309-16.

Reference Type BACKGROUND
PMID: 8762750 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-09

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.